CMR Surgical has struck a £300 million investment deal which could lead to a full takeover.
The Cambridge-headquartered firm has agreed a strategic alliance with New York-listed Stryker to advance its robotic-assisted surgery technology.
Stryker announced the strategic equity investment of approximately £300m, with an exclusive option for it to acquire the remaining equity of CMR Surgical, alongside an exclusive US commercial agency agreement for the latter’s Versius portfolio.
CMR Surgical will continue to lead portfolio development and commercialisation in markets outside the United States.
CMR Surgical’s second-generation robot, with established clinical experience globally, supports a broad range of soft tissue procedures. Designed for real-world operating environments, the Versius platform’s modular architecture supports flexibility across procedures, surgeon access and sites of care, and can help healthcare providers grow robotic adoption within existing operating room workflows.
“This strategic alliance is a significant milestone for CMR and a strong endorsement of the technology, clinical experience and global business we have built,” said Massimiliano Colella, CEO of CMR Surgical.
“Stryker’s investment will give us additional strength to accelerate innovation and the continued global expansion of the Versius portfolio, while its scale and deep customer relationships create a significant growth opportunity in the United States.
Andy Pierce, group president, medsurg and neurotechnology at Stryker, will join CMR Surgical’s board of directors.
“Soft-tissue robotics is a high-growth adjacency and a natural extension of Stryker’s strengths in endoscopy, visualization and enabling technologies. We have evaluated the segment carefully for years, and this alliance represents a thoughtful and disciplined entry that combines the complementary strengths of both companies,” he said.
“We selected CMR Surgical and the Versius portfolio because of the opportunity to help healthcare providers grow robotic-assisted surgery adoption across a broad range of procedures in hospitals and ASCs.”